Venous thromboembolism (VTE) is a serious condition caused by the formation of a blood clot in the venous system with subsequent embolism, which can lead to potentially dangerous complications such as pulmonary embolism. The main mechanism of development of this condition is the violation of blood hemodynamics in the veins, which, in turn, can be provoked by various factors, including prolonged limitation of mobility, injuries, surgeries or the presence of concomitant diseases. VTE has a wide range of clinical manifestations and requires timely diagnosis and adequate treatment to prevent serious consequences that threaten the patient's life.
History of the disease and interesting historical facts
The study of venous thromboembolism dates back to ancient times, when famous physicians and philosophers such as Hippocrates mentioned the connection between the movement and condition of the blood. The modern understanding of VTE began to take shape in the 19th century, when in 1852 the German physician Gustav Rudolf Klucker described pulmonary embolism as a consequence of the migration of a thrombus formed in the deep veins. Later, in the early 20th century, the three-factor theory of venous thrombosis was developed by the Hungarian physician Wentz F. Linder: hypercoagulation, vessel wall damage, and blood stasis. These three factors remain the main ones in explaining the pathogenesis of VTE to this day.
Epidemiology
According to statistics, venous thromboembolism is one of the most common causes of death in the world. According to the World Health Organization, the incidence of VTE reaches 1-2% of the general population, and among people with increased risk factors, this figure can increase to 30%. Thrombus formation is more often observed in older patients, as well as in those who have undergone surgery or trauma. It is also worth noting that, according to meta-analyses, pulmonary thromboembolism occurs in 4-30% patients undergoing inpatient treatment, especially in the postoperative period.
Genetic predisposition to this disease
Genetic predisposition to venous thromboembolism is determined by the presence of many hereditary conditions related to hemostasis. The most well-known of these are mutations in genes encoding blood clotting factors, such as:
- Factor V Leiden - mutation of the F5 gene, which significantly increases the likelihood of venous thrombosis;
- Antithrombin III deficiency - a genetic condition in which there is a deficiency of a blood clot inhibitor;
- Mutation in the protein C gene and squirrel S - important regulators of fibrin and platelet fusion;
- Problems with homocysteine - hyperhomocysteinemia may increase the risk of thrombophlebitis.
These genetic factors can influence the development of venous thromboembolism both independently and in combination with other predisposing factors.
Risk factors for the development of this disease
There are many risk factors that contribute to the development of venous thromboembolism. The main ones include:
- Long-term immobilization — Lack of movement, for example after operations or long trips;
- Injuries and surgeries — Operations on the limbs, pelvic and abdominal injuries;
- Cardiovascular diseases - Arrhythmia, heart failure;
- Obesity — Increased body weight increases the risk of venous thrombosis;
- Diseases that increase blood clotting - Including cancer and inflammatory processes;
- Hormonal therapy — Use of oral contraceptives or hormone replacement therapy.
These factors may interact to create additional health risks that require careful monitoring and intervention.
Diagnosis of this disease
The diagnosis of venous thromboembolism is based on a combination of clinical evaluation, laboratory tests, and radiological methods. The main symptoms may include:
- Swelling of the same limb;
- Pain in the area of the thrombus;
- Increase in temperature;
- Redness and changes in skin color.
Laboratory tests include D-dimer, which may be elevated in the presence of a venous thrombus. Radiological tests such as venous ultrasound and computed tomography are key to establishing the diagnosis. It is also important to differentiate from other conditions such as phlebitis, lymphedema, and arterial insufficiency.
Treatment
Treatment of venous thromboembolism includes both conservative and surgical methods. The main focus is on pharmacological therapy, among which the following are important elements:
- Anticoagulants - drugs that inhibit blood clotting, such as warfarin, dabigatran, rivaroxaban;
- Thrombolytics - used to dissolve already formed blood clots;
- Compression therapy - maintains venous blood flow and reduces swelling.
In severe cases, surgical intervention is indicated, for example, the installation of a cavofilter to prevent the migration of blood clots to the lungs.
List of medications used to treat this disease
There are a number of medications used in the treatment of venous thromboembolism:
- Warfarin;
- Dabigatran;
- Rivaroxaban;
- Apixaban;
- Utrocaine;
- Tenecteplaz;
- Squazol.
These drugs allow for effective control of the coagulation process and prevention of relapses.
Disease monitoring
Monitoring of venous thromboembolism should include controlled stages to assess the effectiveness of the treatment and prevent relapses. The prognosis of the disease largely depends on timely diagnosis and treatment. The main complications may be:
- Recurrence of venous thrombosis;
- Pulmonary thromboembolism;
- Chronic venous insufficiency.
Regular clinical examinations and laboratory tests are important to monitor the condition of patients.
Age-related features of the disease
Venous thromboembolism may present differently depending on the age group. In young people, the disease is often associated with trauma or surgery, while in older patients, VTE is more often observed as a result of terminal metabolism and concomitant diseases. In children, this syndrome is generally rare, but may occur as a result of congenital pathologies of blood clotting.
Questions and Answers
- What are the main symptoms of venous thromboembolism? The main symptoms include swelling of the limb, pain, redness and increased temperature along the venous bed.
- How is venous thromboembolism diagnosed? Diagnosis includes clinical examination, D-dimer testing, and imaging (ultrasound or CT).
- What treatment is prescribed for VTE? Treatment may include anticoagulants, thrombolytics and, in severe cases, surgery.
- What are the risk factors for venous thromboembolism? Major risk factors include prolonged immobilization, trauma, obesity, and inherited hemostatic disorders.
- What is the prognosis for venous thromboembolism? The prognosis depends on the speed of diagnosis and initiation of treatment; with proper therapy, most patients recover without complications.
